Evidence map›Paper›PMID 36203941›Full record

ArticleFrontiers in physiology2022

Kaushalya Amunugama, Daniel P Pike, David A Ford

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. PathogenicMicrobial cell (Graz, Austria) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kaushalya AmunugamaEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Daniel P PikeEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.
David A FordEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Saint Louis University · US

Funding

Chlorinated lipids in sepsisR01GM115553 · NIGMS · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A., MCHOWAT, JANE · 2015 to 2021
$3.0M
Liquid Chromatography/ESI-MS Triple Quadrupole SystemS10OD025246 · OD · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2019 to 2019
$244k
Plasmalogen-Derived Chlorinated Lipids: Mediators of Acute Lung Injury in SepsisF30HL142193 · NHLBI · SAINT LOUIS UNIVERSITY · PI PIKE, DANIEL · 2018 to 2021
$160k
NHLBI NIH HHS F30 HL142193NIGMS NIH HHS R01 GM115553NIH HHS S10 OD025246
6 · The paper itself

Abstract

Dysregulated lipid metabolism is common in infection and inflammation and is a part of the complex milieu underlying the pathophysiological sequelae of disease. Sepsis is a major cause of mortality and morbidity in the world and is characterized by an exaggerated host response to an infection. Metabolic changes, including alterations in lipid metabolism, likely are important in sepsis pathophysiology. Here, we designed an

Indexed as

E. coliendothelial cellsinfectionlipidomicslipidsneutrophilssepsis

Identifiers

PMID36203941
PMCPMC9530349
OpenAlexW4296389999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.